A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin

NCT01094483 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Platelet Inhibition

Interventions

DRUG: PN400
DRUG: ASA
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]